Literature DB >> 2578046

Studies on the synthesis and secretion of interleukin 1. I. A 33,000 molecular weight precursor for interleukin 1.

J G Giri, P T Lomedico, S B Mizel.   

Abstract

Previous studies have suggested that murine interleukin 1 (IL 1) may be synthesized as a high m.w. precursor. Using specific antibodies against murine IL 1, we have analyzed the primary form of IL 1 synthesized by normal peritoneal macrophages and P388D1 cell line macrophages, and in vitro using poly (A)+ RNA from stimulated normal and cell line macrophages. In all cases, the labeled protein immunoprecipitated with the anti-IL 1 antibodies exhibited a m.w. of 33,000 on SDS gels. This 33,000 m.w. protein was not an aggregate of low m.w. IL 1. Addition of excess purified low m.w. IL 1 completely blocked the immunoprecipitation of the 33,000 m.w. protein. When cells were pulsed with [35S]methionine for 1 to 5 hr and then incubated in medium containing unlabeled methionine for 19 hr, labeled low m.w. IL 1 was detected in the culture fluid. If cells were pulsed with [35S]methionine to label the 33,000 m.w. protein and then incubated in the presence of a maximally effective concentration of the protein synthesis inhibitor, cycloheximide, the low m.w. IL 1 was still found in the culture fluid. Our results indicate that IL 1 is synthesized as a 33,000 m.w. precursor that is converted to the low m.w. form that is found in the culture fluid of stimulated murine macrophages.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578046

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

Review 1.  Interleukin 1α and the inflammatory process.

Authors:  Nelson C Di Paolo; Dmitry M Shayakhmetov
Journal:  Nat Immunol       Date:  2016-07-19       Impact factor: 25.606

2.  Interleukin-1 induces chondrocyte protease production: the development of collagenase inhibitors.

Authors:  R D Pasternak; S J Hubbs; R G Caccese; R L Marks; J M Conaty; G DiPasquale
Journal:  Agents Actions       Date:  1987-08

3.  Identification of a monocyte specific pre-interleukin 1 beta convertase activity.

Authors:  M J Kostura; M J Tocci; G Limjuco; J Chin; P Cameron; A G Hillman; N A Chartrain; J A Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  Effects of serine protease inhibitor, TAME, on IL-1 beta in LPS-stimulated human monocytes: relationship between synthesis and release of a 33-kDa precursor and the 17-kDa biologically active species.

Authors:  J J Jessop; S L Henry; T Hoffman
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

5.  Cell cycle-dependent interleukin 1 gene expression by cultured glomerular mesangial cells.

Authors:  D H Lovett; A Larsen
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

6.  Acylation of monocyte and glomerular mesangial cell proteins. Myristyl acylation of the interleukin 1 precursors.

Authors:  S L Bursten; R M Locksley; J L Ryan; D H Lovett
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

7.  Antibodies of predetermined specificity to the major charged species of human interleukin 1.

Authors:  G Limjuco; S Galuska; J Chin; P Cameron; J Boger; J A Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  Stimulation of monokine production by lipoteichoic acids.

Authors:  S Bhakdi; T Klonisch; P Nuber; W Fischer
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

9.  The human prointerleukin 1 beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction.

Authors:  F Shirakawa; K Saito; C A Bonagura; D L Galson; M J Fenton; A C Webb; P E Auron
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

10.  Anti-proinflammatory effects of sirolimus on human islet preparations.

Authors:  Atsuyoshi Mita; Camillo Ricordi; Atsushi Miki; Scott Barker; Ross Haertter; Yasuhiko Hashikura; Shin-Ichi Miyagawa; George W Burke; Luca Inverardi; Hirohito Ichii
Journal:  Transplantation       Date:  2008-07-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.